Publication | Closed Access

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

Hematological MalignancyCell Cycle ProgressionCell DivisionCell RegulationCdk Inhibitor P27MedicineMalignant Blood DisorderImmunologyCyclin D2Cell CycleAdult T-cell Leukemia-lymphomaOncologyCell BiologyCell SignalingTumor Biology